Praveen Nasa

Praveen Nasa

Auto-generated profile, based on publicly available information

Praveen Nasa

Department of Pharmaceutical Education and Research, Bhagat Phool Singh Mahila Vishwavidyalaya, Khanpur Kalan, Sonipat, Haryana, India

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2026 in Current Rheumatology Reviews
Verified
Journal Article
Closed access
PDF file
KSK. Sunand
K. Sunand
ATArpan Kumar Tripathi
Arpan Kumar Tripathi
APAkhilesh Patel
Akhilesh Patel
PNPraveen Nasa
Praveen Nasa
SAShadab Ali
Shadab Ali
SSShamim Shamim
Shamim Shamim
Rheumatoid arthritis is a chronic autoimmune disorder marked by persistent inflammation, synovial hyperplasia, and joint destruction. Despite advances in targeted biologics and disease-modifying antirheumatic drugs, treatment challenges persist due to incomplete responses, adverse effects, and high costs. This has spurred interest in natural bioactive compounds as multi-target therapeutic agents. Derived from plant, marine, and microbial sources, natural bioactive compounds including polyphenols, flavonoids, alkaloids, and terpenoids demonstrate pleiotropic effects such as anti-inflammatory, antioxidant, immunomodulatory, and antiproliferative actions. They modulate key Rheumatoid arthritis pathways like NF-κB, JAK/STAT, MAPK, and Nrf2, inhibit pro-inflammatory cytokines, and restore immune balance through Th17/Treg regulation. Epigenetic modulation via microRNAs and histone deacetylase inhibition adds a durable therapeutic dimension. Preclinical studies highlight natural bioactive compound's efficacy in reducing cytokine storms, oxidative stress, and fibroblast-like synoviocyte proliferation. Clinical trials involving curcumin, resveratrol, and boswellic acids show improved disease activity scores, pain, and inflammatory biomarkers. However, poor bioavailability remains a significant limitation, now being addressed through nanotechnology-based delivery systems such as liposomes and phytosomes. The downside of natural bioactive compounds is their low toxicity profile and capability to support conventional treatments, although specific regulatory and pharmacokinetic challenges persist. Combining systems biology with artificial intelligence and personalized medicine demonstrates the potential for enhancing treatment impact through natural bioactive compounds-based interventions in Rheumatoid arthritis patients. The accumulation of medical evidence suggests that natural bioactive compounds may develop into secure treatments that extend across multiple targets or support the complete management of Rheumatoid Arthritis.

16 October 2026 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
ABAkash Bhati
Akash Bhati
NSNavneet Sharma
Navneet Sharma
BBBharat Bhusan
Bharat Bhusan
PNPraveen Nasa
Praveen Nasa
DBDeepika Bhatia
Deepika Bhatia
HDHitesh Kumar Dewangan
Hitesh Kumar Dewangan
Morus alba L., a member of the Moraceae family, is widely recognised for its medicinal and nutritional importance. Various extracts from Traditional Chinese, Ayurvedic, and Korean medicine systems are widely used, including tree leaves, fruits, root bark, and branches. This review critically summarises the pharmacological potential, phytochemical profile, and emerging therapeutic applications of Morus alba L. based on available preclinical and analytical studies. These activities are attributed to diverse bioactive constituents, including stilbenes, anthocyanins, phenolic acids, alkaloids, and flavonoids. Besides, the plant is important in sericulture and offers possible health advantages as a health supplement, herbal tea, jams, oils, and functional foods. This review compiles and evaluates extraction and analytical techniques used for the identification and characterisation of bioactive compounds from Morus alba. These include HPLC, GC-MS, NMR, ethanol-based extraction, hot water extraction, and advanced proteomic and metabolomic approaches. Chemometric tools, along with HPLC-DAD and UHPLC-ESI-MSn, are widely used for quality assessment and chemical standardisation. Recent studies in emerging areas such as molecular docking, ligand fishing, and nanoparticle-based systems further highlight its potential in drug discovery and delivery. Morus alba-mediated nanoparticles have also demonstrated antimicrobial, antioxidant, and drug delivery potential. This review highlights current evidence, identifies research gaps, and provides future directions for the development of Morus alba-based therapeutic and functional applications.